SnapBill MD
All codes

G381 – Standard chemotherapy - agents with minor toxicity

OHIP Diagnostic and Therapeutic Procedures Code — DIAGNOSTIC AND THERAPEUTIC PROCEDURES · Schedule of Benefits

Chemotherapy (pharmacologic therapy of malignancy or autoimmune disease) - with administration supervised by a physician for intravenous infusion for treatment of malignant or autoimmune disease. The physician must be available to intervene in a timely fashion at the initiation and for the duration of the prescribed therapy to manage immediate and delayed toxicities. Chemotherapy and patient assessment provided by a physician includes all patient assessments by any physician for a 24 hour period following treatment administration. G381 is only eligible for payment with respect to the following classes of biologic agents: monoclonal antibodies and cytokines. G381 includes venipuncture, establishment of any vascular access line and administration of agent(s). Examples that are not considered biologic agents for payment purposes are blood products, insulin, and immunizing agents.
The medical record must document that the physician supervised the administration and was available to intervene in a timely fashion at the initiation and for the duration of the prescribed therapy to manage toxicities.
As per general requirements on , all insured services must be documented in the medical record to establish that the service was provided, is the service for which the account is submitted, and was medically necessary.

1. G381, G281, G345 and G359 are only eligible for payment with respect to the following classes of biologic agents: a. monoclonal antibodies; and b. cytokines.

2. G381, G281, G345, G359, G075 and G390 include venipuncture, establishment of any vascular access line and administration of agent(s).

Ready to bill this code?

SnapBill makes OHIP billing simple — auto-filled codes, validation, and batch submission.

We use cookies to measure site usage and improve your experience. You can manage your preferences at any time.